Abstract
Faithful genome transmission requires the cooperation of a network of pathways including cell cycle checkpoint, DNA replication, repair and recombination. The different DNA repair pathways must also be coordinated as function of the type of damage, the cell cycle and differentiation. DNA double-strand breaks (DSBs) are highly toxic lesions, which can be produced by physiological cell processes, such as meiosis or V(D)J recombination or by genotoxic stresses, such as ionizing radiation or replication inhibition. In mammalian cells, two major classes of processes can repair DSBs: non-homologous end-joining (NHEJ) or homologous recombination (HR). It has been proposed that the two processes can compete, via the binding to the broken DNA ends by the Ku80-Ku70 heterodimer (NHEJ) versus RAD52 protein (HR). Consistent with the competition for the DNA ends model, mammalian NHEJ defective cells show increased HR, induced by DSB generating treatment; this stimulation is specific to DSB since neither spontaneous nor UV-C-induced HR are stimulated. However the regulation could be more complex since different cell situations can affect the choice between NHEJ and HR, such as the stage of embryonic development, the persistence and / or accumulation of DSBs. The phase of the cell cycle has also been proposed to affect this channeling. In addition, despite the cell cycle regulation, the two processes can cooperate or act sequentially. After describing the molecular mechanisms of NHEJ and HR processes, their regulation is presented and discussed in this review. A model of regulation of DSB repair with respect to the cell cycle is proposed.
Keywords: homologous recombination, non-homologous recombination, nhej, double-strand breaks, ionizing radiation, mammalian cells
Current Genomics
Title: Homologous Recombination, Non-Homologous End-Joining and Cell Cycle: Genomes Angels
Volume: 5 Issue: 1
Author(s): Delacote F., Guirouilh-Barbat J., Lambert S. and B. S. Lopez
Affiliation:
Keywords: homologous recombination, non-homologous recombination, nhej, double-strand breaks, ionizing radiation, mammalian cells
Abstract: Faithful genome transmission requires the cooperation of a network of pathways including cell cycle checkpoint, DNA replication, repair and recombination. The different DNA repair pathways must also be coordinated as function of the type of damage, the cell cycle and differentiation. DNA double-strand breaks (DSBs) are highly toxic lesions, which can be produced by physiological cell processes, such as meiosis or V(D)J recombination or by genotoxic stresses, such as ionizing radiation or replication inhibition. In mammalian cells, two major classes of processes can repair DSBs: non-homologous end-joining (NHEJ) or homologous recombination (HR). It has been proposed that the two processes can compete, via the binding to the broken DNA ends by the Ku80-Ku70 heterodimer (NHEJ) versus RAD52 protein (HR). Consistent with the competition for the DNA ends model, mammalian NHEJ defective cells show increased HR, induced by DSB generating treatment; this stimulation is specific to DSB since neither spontaneous nor UV-C-induced HR are stimulated. However the regulation could be more complex since different cell situations can affect the choice between NHEJ and HR, such as the stage of embryonic development, the persistence and / or accumulation of DSBs. The phase of the cell cycle has also been proposed to affect this channeling. In addition, despite the cell cycle regulation, the two processes can cooperate or act sequentially. After describing the molecular mechanisms of NHEJ and HR processes, their regulation is presented and discussed in this review. A model of regulation of DSB repair with respect to the cell cycle is proposed.
Export Options
About this article
Cite this article as:
F. Delacote, J. Guirouilh-Barbat, S. Lambert and Lopez S. B., Homologous Recombination, Non-Homologous End-Joining and Cell Cycle: Genomes Angels, Current Genomics 2004; 5 (1) . https://dx.doi.org/10.2174/1389202043490041
DOI https://dx.doi.org/10.2174/1389202043490041 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Rethinking Target Discovery in Polygenic Diseases
Current Topics in Medicinal Chemistry Design, Synthesis, and Structure-Activity Relationship Study of Peroxisome Proliferator-Activated Receptor (PPAR) δ-Selective Ligands
Current Medicinal Chemistry Cancer Chemoprevention with Green Tea Catechins: From Bench to Bed
Current Drug Targets Piper sarmentosum Roxb. Root Extracts Confer Neuroprotection by Attenuating Beta Amyloid-Induced Pro-Inflammatory Cytokines Released from Microglial Cells
Current Alzheimer Research Endoplasmic Reticulum Stress in Chronic Obstructive Lung Diseases
Current Molecular Medicine Osteoporosis Entwined with Cardiovascular Disease: The Implication of Osteoprotegerin and the Example of Statins
Current Medicinal Chemistry Lipid A Biosynthesis of Multidrug-Resistant Pathogens - A Novel Drug Target
Current Pharmaceutical Design Editorial:
Drug Metabolism Letters The Radiosensitizing Effect of Olanzapine as an Antipsychotic Medication on Glioblastoma Cell
Current Radiopharmaceuticals Diabetes Mellitus: A Potential Target for Stem Cell Therapy
Current Stem Cell Research & Therapy Neuroprotective Strategies in Glaucoma
Current Pharmaceutical Design Sleep Duration as a Risk Factor for Cardiovascular Disease- a Review of the Recent Literature
Current Cardiology Reviews Melatonin Attenuates Methamphetamine-Induced Neurotoxicity
Current Pharmaceutical Design Platelet Activation, Inflammatory Mediators and Hypercholesterolemia
Current Vascular Pharmacology Vaccine Therapy for P. acnes-Associated Diseases
Infectious Disorders - Drug Targets Assessment of Retinal Structural and Functional Characteristics in Eyes with Autoimmune Retinopathy
Current Molecular Medicine <sup>1</sup>H and <sup>13</sup>C NMR Spectral Data of Neolignans Isolated from <i>Piper</i> Species
Current Organic Chemistry Nonstandard Drugs and Feasible New Interventions for Autoimmune Hepatitis: Part II
Inflammation & Allergy - Drug Targets (Discontinued) Pharmacophore Modeling and Three Dimensional Database Searching for Drug Design Using Catalyst: Recent Advances
Current Medicinal Chemistry Targeting Proteasomal Pathways by Dietary Curcumin for Cancer Prevention and Treatment
Current Medicinal Chemistry